Genetic variants of the MIR31HG gene are related to a risk of IgA nephropathy

•Rs1332184 and rs55683539 in MIR31HG strongly related to an increased risk of IgAN.•Rs72703442, rs55683539, and rs10965064 strongly enhanced IgAN risk in age ≤ 35 years.•Rs1332184, rs55683539 and rs2181559 significantly increased IgAN risk in males.•Rs1332184 and rs55683539 correlated with IgAN risk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunopharmacology 2020-07, Vol.84, p.106533-106533, Article 106533
Hauptverfasser: Yuan, Haozheng, Li, Siyuan, Wang, Li, Zhao, Xijuan, Xue, Li, Lei, Xiaoming, Fu, Rongguo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Rs1332184 and rs55683539 in MIR31HG strongly related to an increased risk of IgAN.•Rs72703442, rs55683539, and rs10965064 strongly enhanced IgAN risk in age ≤ 35 years.•Rs1332184, rs55683539 and rs2181559 significantly increased IgAN risk in males.•Rs1332184 and rs55683539 correlated with IgAN risk stratified by Lee’s grade.•Rs72703442 and rs10965064 SNP related to clinical indicators such as HB and Urine RBC. IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. Previous studies reveal that genetic factors play a crucial role in IgAN progression. This study was conducted to investigate the association between MIR31HG variants and IgAN risk. A total of 836 subjects were recruited to detect the relationship of MIR31HG variants with IgAN susceptibility. Odds ratios (OR) and 95% confidence intervals (CI) were computed to evaluate the associations. Multifactor dimensionality reduction was performed to analyze the SNP-SNP interaction with IgAN risk. Our study showed that rs1332184 and rs55683539 significantly related to an increased risk of IgAN (OR 1.34, p = 0.041; OR 1.39, p = 0.025). Stratified analyses indicated rs72703442, rs55683539, and rs10965064 exhibited strongly enhanced risk of IgAN in age ≤ 35 years (OR 1.55, p = 0.023; OR 1.60, p = 0.012; OR 1.46, p = 0.037). Besides, we found rs1332184, rs55683539 and rs2181559 significantly increased the susceptibility of IgAN in males (OR 1.71, p = 0.003; OR 1.44, p = 0.042; OR 1.60, p = 0.010). We also observed that rs1332184 could enhance IgAN risk for Lee’s grade ≥ III (OR 1.39, p = 0.045). Rs55683539 significantly increased a risk of IgAN (OR 1.58, p = 0.027), while rs2025327 had a lower risk of IgAN in Lee’s grade 
ISSN:1567-5769
1878-1705
DOI:10.1016/j.intimp.2020.106533